Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Treasury Shares (2020 - 2024)

Tandem Diabetes Care filings provide 6 years of Treasury Shares readings, the most recent being $297456.0 for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 92.04% to $297456.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $297456.0, a 92.04% decrease, with the full-year FY2025 number at $297456.0, down 92.04% from a year prior.
  • Treasury Shares hit $297456.0 in Q4 2025 for Tandem Diabetes Care, down from $3.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.7 million in Q4 2024 to a low of $297456.0 in Q4 2025.
  • Median Treasury Shares over the past 5 years was $1.8 million (2022), compared with a mean of $1.9 million.
  • Biggest five-year swings in Treasury Shares: soared 359.88% in 2021 and later crashed 92.04% in 2025.
  • Tandem Diabetes Care's Treasury Shares stood at $610731.0 in 2021, then skyrocketed by 200.27% to $1.8 million in 2022, then skyrocketed by 73.2% to $3.2 million in 2023, then grew by 17.71% to $3.7 million in 2024, then crashed by 92.04% to $297456.0 in 2025.
  • The last three reported values for Treasury Shares were $297456.0 (Q4 2025), $3.7 million (Q4 2024), and $3.2 million (Q4 2023) per Business Quant data.